Generics

Innovative Products found!

Biosimilars

Medical devices

Nutraceuticals

Filters

Pp-089 manufacturers

Filters

Filters

Filters , active

Country of origin : Japan

Clear all

1 products found

pp-089

Injection

Dossier type
CTD
Dossier status
Under development
Country of origin
Japan
Comments
Indication: Psoriasis requiring systemic immunomodulation. Clinical stage: Phase 2a. Modality: Antibody-inducing peptide vaccine. Mechanism / Target: Induces neutralizing anti–IL-17A antibodies using AJP001 helper-T-cell epitope to activate B-cell responses. Route / form: Subcutaneous injection. Differentiation: Demonstrated dose-dependent antibody generation and good tolerability; offers vaccine-based IL-17A inhibition as an alternative to monoclonal antibodies.
Manufacturer #38644

A clinical-stage biotechnology firm advancing functional and antibody-inducing peptide medicines to address immune, skin and inflammatory conditions with aims to reduce patient burden versus traditional biologics. It builds on academic peptide technology with global R&D and strategic collaborations. The organization leverages peptide platforms for next-generation vaccines and therapeutic candidates.

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.